Literature DB >> 10401996

The neuromuscular transmission fade (Wedensky inhibition) induced by L-arginine in neuromuscular preparations from rats.

H M Silva1, C R Ambiel, W Alves-Do-Prado.   

Abstract

L-Arginine (4.7-18.8 mM) and 3-(4-morpholinyl)-sydonone imine hydrochloride (SIN-1; 1.15 mM) induced an increase in tetanic fade caused by indirect stimulation (180-200 Hz) of muscle. However, Wedensky inhibition, different from control, was not observed when the preparations treated with d-tubocurarine were directly stimulated by the same frequency. D-Arginine (9.4 mM) was ineffective in changing R values caused by indirect stimulation (180-200 Hz) of muscle. N(omega)-Nitro-L-arginine (73 mM) or 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ; 10 microM) did not produce any effect on Wedensky inhibition but did antagonize the tetanic fade induced by L-arginine (9.4 mM). The SIN-1 effect was antagonized by previous administration of ODQ (108 microM), which alone did not produce any effects on R values. These results indicate that NO acting at the presynaptic level increases the Wedensky inhibition induced by high frequency of stimulation applied on motor nerves, and its effect may be produced through the cGMP-GC pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10401996     DOI: 10.1016/s0306-3623(98)00230-4

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  2 in total

1.  L-citrulline inhibits [3H]acetylcholine release from rat motor nerve terminals by increasing adenosine outflow and activation of A1 receptors.

Authors:  A Barroso; L Oliveira; E Campesatto-Mella; C Silva; M A Timóteo; M T Magalhães-Cardoso; W Alves-do-Prado; P Correia-de-Sá
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

2.  Presynaptic M1, M2, and A1 receptors play roles in tetanic fade induced by pancuronium or cisatracurium.

Authors:  Elaine Campana Sanches Bornia; Erika Bando; Miguel Machinski; Monalisa Wolski Pereira; Wilson Alves-Do-Prado
Journal:  J Anesth       Date:  2009-11-18       Impact factor: 2.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.